CDC- BRFSS – ACBS 2022 Adult Prevalence Table 8

Print
Related Pages
Table 8: Estimated percent using inhaled short acting beta agonists among adults1 with current2 asthma status by state/territory – BRFSS Asthma Call-back Survey, United States, 2022.
State/Territory Current
Sample
size±		 % SE§ 95% CI†
Arizona 328 45.0 5.0 (35.2 – 54.8)
California 307 45.0 4.2 (36.8 – 53.2)
Connecticut 490 56.9 3.3 (50.4 – 63.4)
Florida 449 51.7 4.6 (42.7 – 60.7)
Georgia 329 51.0 4.7 (41.8 – 60.2)
Hawaii 204 33.4 5.4 (22.8 – 44.0)
Indiana 474 52.6 2.9 (46.9 – 58.3)
Iowa 287 60.2 3.9 (52.6 – 67.8)
Kansas 233 45.1 4.7 (35.9 – 54.3)
Maine 351 54.3 4.2 (46.1 – 62.5)
Maryland 387 48.7 4.0 (40.9 – 56.5)
Massachusetts 328 48.2 4.1 (40.2 – 56.2)
Michigan 502 48.4 3.0 (42.5 – 54.3)
Minnesota 539 54.8 2.8 (49.3 – 60.3)
Missouri 237 58.0 4.8 (48.6 – 67.4)
Nebraska 158 54.3 6.0 (42.5 – 66.1)
New Hampshire 379 49.4 4.0 (41.6 – 57.2)
New Jersey 296 53.5 3.9 (45.9 – 61.1)
New Mexico 158 53.8 5.5 (43.0 – 64.6)
New York 314 42.9 3.7 (35.6 – 50.2)
Ohio 405 51.0 3.8 (43.6 – 58.4)
Oregon 139 50.9 5.3 (40.5 – 61.3)
Rhode Island 237 53.4 4.6 (44.4 – 62.4)
Texas 279 52.5 5.1 (42.5 – 62.5)
Utah 308 52.1 3.8 (44.7 – 59.5)
Vermont 498 51.4 2.9 (45.7 – 57.1)
Wisconsin 395 56.0 3.4 (49.3 – 62.7)
Puerto Rico 260 40.2 4.4 (31.6 – 48.8)
28 States / Area 9,271 49.0 1.2 (46.6 – 51.4)
Median 51.6
Range 33.4-60.2

1 Aged ≥ 18 years

2 “Yes” response to “Do you still have asthma?”

± Sample size for adults with current asthma, excludes “DK/Refused”

§ Standard error

† Confidence interval

Link for Summary Data Quality Report: https://www.cdc.gov/brfss/acbs/2022/pdf/sdq_report_acbs_22-508.pdf